Artificial sweetener approved by the FDA in 1981 after Donald Rumsfeld, then CEO of G.D. Searle, lobbied the agency during a revolving-door appointment.
Aspartame, a synthetic sugar substitute developed by G.D. Searle & Company in the 1960s, faced significant FDA scrutiny before its approval in 1981. The approval process became notable when Donald Rumsfeld served as CEO of Searle from 1977 to 1985, a period that included his government service. Rumsfeld's political connections and advocacy for the product coincided with regulatory approval, raising documented questions about potential conflicts of interest in the approval process.
Historical records show that Searle submitted extensive testing data to the FDA, but independent scientists raised concerns about study methodology in the 1970s. The FDA's 1981 approval came after Arthur Hull Hayes Jr. became FDA Commissioner in 1981, a decision that accelerated the timeline. Rumsfeld's subsequent role in the Reagan administration, including as Defense Secretary (1981-1989), cemented what critics viewed as a classic example of regulatory capture—where industry influence shaped government decisions affecting public health.
